Drug Reduces Daily 'Off' Time For Parkinson Patients
Parkinson Disease Drug
Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness, and walking difficulty return as drugs wear off.
The study involved 393 people with Parkinson disease who weren't responding optimally to the widely used treatment for Parkinson, levodopa. For the study, half of the group took the prolonged release version of the drug ropinirole, called ropinirole 24-hour, and levodopa for six months. The other half took placebo and levodopa. Other Parkinson disease medications were not changed during the study.
Researchers found those people taking the drug reduced their average daily "off" time by 2.1 hours compared to .3 hours in the placebo group.
"Ropinirole 24-hour prolonged release, when taken with levodopa, is effective in reducing daily